Your browser doesn't support javascript.
loading
CHARGE syndrome and related disorders: a mechanistic link.
Ufartes, Roser; Grün, Regina; Salinas, Gabriela; Sitte, Maren; Kahl, Fritz; Wong, Monica T Y; van Ravenswaaij-Arts, Conny M A; Pauli, Silke.
Afiliación
  • Ufartes R; Institute of Human Genetics, University Medical Center Göttingen, Göttingen 37073, Germany.
  • Grün R; Institute of Human Genetics, University Medical Center Göttingen, Göttingen 37073, Germany.
  • Salinas G; NGS Integrative Genomics Core Unit, University Medical Center Göttingen, Göttingen 37073, Germany.
  • Sitte M; NGS Integrative Genomics Core Unit, University Medical Center Göttingen, Göttingen 37073, Germany.
  • Kahl F; Department of General-, Visceral- and Pediatric Surgery, University Medical Center Göttingen, UMG, Göttingen, Germany.
  • Wong MTY; University of Groningen, University Medical Center Groningen, Department of Genetics, RB, Groningen 9700, The Netherlands.
  • van Ravenswaaij-Arts CMA; University of Groningen, University Medical Center Groningen, Department of Genetics, RB, Groningen 9700, The Netherlands.
  • Pauli S; Institute of Human Genetics, University Medical Center Göttingen, Göttingen 37073, Germany.
Hum Mol Genet ; 30(23): 2215-2224, 2021 11 16.
Article en En | MEDLINE | ID: mdl-34230955
ABSTRACT
CHARGE syndrome is an autosomal dominant malformation disorder caused by pathogenic variants in the chromatin remodeler CHD7. Affected are craniofacial structures, cranial nerves and multiple organ systems. Depending on the combination of malformations present, its distinction from other congenital disorders can be challenging. To gain a better insight into the regulatory disturbances in CHARGE syndrome, we performed RNA-Seq analysis on blood samples of 19 children with CHARGE syndrome and a confirmed disease-causing CHD7 variant in comparison with healthy control children. Our analysis revealed a distinct CHARGE syndrome pattern with downregulation of genes that are linked to disorders described to mimic the CHARGE phenotype, i.e. KMT2D and KDM6A (Kabuki syndrome), EP300 and CREBBP (Rubinstein-Taybi syndrome) and ARID1A and ARID1B (Coffin-Siris syndrome). Furthermore, by performing protein-protein interaction studies using co-immunoprecipitation, direct yeast-two hybrid and in situ proximity ligation assays, we could demonstrate an interplay between CHD7, KMT2D, KDM6A and EP300. In summary, our data demonstrate a mechanistic and regulatory link between the developmental disorders CHARGE-, Kabuki- and Rubinstein Taybi-syndrome providing an explanation for the overlapping phenotypes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Estudios de Asociación Genética / Síndrome CHARGE / Enfermedades Genéticas Congénitas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Estudios de Asociación Genética / Síndrome CHARGE / Enfermedades Genéticas Congénitas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2021 Tipo del documento: Article País de afiliación: Alemania